By Nikki Kean
ATLANTA—To help prescribers and pharmacists better navigate the use of biosimilars, the American College of Rheumatology (ACR) has published a new white paper, “The Science Behind Biosimilars: Entering a New Era of Biologic Therapy” (Arthritis Rheum 2018;70[3]:334-344).
MARCH 2, 2018